CH Biotech R&D Co (TPE:6534) 5-Year EBITDA Growth Rate : 24.30% (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co 5-Year EBITDA Growth Rate?

CH Biotech R&D Co's EBITDA per Share for the three months ended in Mar. 2025 was NT$5.37.

During the past 12 months, CH Biotech R&D Co's average EBITDA Per Share Growth Rate was -4.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 17.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of CH Biotech R&D Co was 45.20% per year. The lowest was -18.70% per year. And the median was 8.25% per year.

Competitive Comparison of CH Biotech R&D Co's 5-Year EBITDA Growth Rate

For the Agricultural Inputs subindustry, CH Biotech R&D Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CH Biotech R&D Co's 5-Year EBITDA Growth Rate Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CH Biotech R&D Co's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

CH Biotech R&D Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CH Biotech R&D Co (TPE:6534) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

CH Biotech R&D Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CH Biotech R&D Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CH Biotech R&D Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 89, Wenxian Road, Nantou County, Nantou, TWN, 540001

Website

https://www.chbio.com.tw

CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.

CH Biotech R&D Co Headlines

No Headlines